載入...
Soluble Guanylate Cyclase: A new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Nitric oxide (NO) activates soluble guanylate cyclase (sGC) by binding its prosthetic heme group, thereby catalyzing cyclic guanosine monophosphate (cGMP) synthesis. cGMP causes vasodilation and may inhibit smooth muscle cell proliferation and platelet aggregation. The NO-sGC-cGMP pathway is disorde...
Na minha lista:
| 發表在: | Clin Pharmacol Ther |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4325399/ https://ncbi.nlm.nih.gov/pubmed/25670386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.10 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|